IBDEI2X1 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46503,0)
;;=H34.8110^^176^2313^22
;;^UTILITY(U,$J,358.3,46503,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46503,1,3,0)
;;=3^CRVO w/ CME,RIGHT eye
;;^UTILITY(U,$J,358.3,46503,1,4,0)
;;=4^H34.8110
;;^UTILITY(U,$J,358.3,46503,2)
;;=^5138476
;;^UTILITY(U,$J,358.3,46504,0)
;;=H34.8120^^176^2313^23
;;^UTILITY(U,$J,358.3,46504,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46504,1,3,0)
;;=3^CRVO w/ CME,LEFT eye
;;^UTILITY(U,$J,358.3,46504,1,4,0)
;;=4^H34.8120
;;^UTILITY(U,$J,358.3,46504,2)
;;=^5138479
;;^UTILITY(U,$J,358.3,46505,0)
;;=H21.1X1^^176^2313^24
;;^UTILITY(U,$J,358.3,46505,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46505,1,3,0)
;;=3^NVI/NVA/Rubeosis,RIGHT eye
;;^UTILITY(U,$J,358.3,46505,1,4,0)
;;=4^H21.1X1
;;^UTILITY(U,$J,358.3,46505,2)
;;=^5005175
;;^UTILITY(U,$J,358.3,46506,0)
;;=H21.1X2^^176^2313^25
;;^UTILITY(U,$J,358.3,46506,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46506,1,3,0)
;;=3^NVI/NVA/Rubeosis,Left eye
;;^UTILITY(U,$J,358.3,46506,1,4,0)
;;=4^H21.1X2
;;^UTILITY(U,$J,358.3,46506,2)
;;=^5005176
;;^UTILITY(U,$J,358.3,46507,0)
;;=H35.711^^176^2313^26
;;^UTILITY(U,$J,358.3,46507,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46507,1,3,0)
;;=3^Central Serous Retinopathy,RIGHT eye
;;^UTILITY(U,$J,358.3,46507,1,4,0)
;;=4^H35.711
;;^UTILITY(U,$J,358.3,46507,2)
;;=^5005703
;;^UTILITY(U,$J,358.3,46508,0)
;;=H35.712^^176^2313^27
;;^UTILITY(U,$J,358.3,46508,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46508,1,3,0)
;;=3^Central Serous Retinopathy,LEFT eye
;;^UTILITY(U,$J,358.3,46508,1,4,0)
;;=4^H35.712
;;^UTILITY(U,$J,358.3,46508,2)
;;=^5005704
;;^UTILITY(U,$J,358.3,46509,0)
;;=E11.9^^176^2314^2
;;^UTILITY(U,$J,358.3,46509,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46509,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,46509,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,46509,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,46510,0)
;;=E11.39^^176^2314^1
;;^UTILITY(U,$J,358.3,46510,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46510,1,3,0)
;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
;;^UTILITY(U,$J,358.3,46510,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,46510,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,46511,0)
;;=E10.9^^176^2314^21
;;^UTILITY(U,$J,358.3,46511,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46511,1,3,0)
;;=3^DM Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,46511,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,46511,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,46512,0)
;;=E10.39^^176^2314^20
;;^UTILITY(U,$J,358.3,46512,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46512,1,3,0)
;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
;;^UTILITY(U,$J,358.3,46512,1,4,0)
;;=4^E10.39
;;^UTILITY(U,$J,358.3,46512,2)
;;=^5002603
;;^UTILITY(U,$J,358.3,46513,0)
;;=E10.3291^^176^2314^22
;;^UTILITY(U,$J,358.3,46513,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46513,1,3,0)
;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Right Eye
;;^UTILITY(U,$J,358.3,46513,1,4,0)
;;=4^E10.3291
;;^UTILITY(U,$J,358.3,46513,2)
;;=^5138283
;;^UTILITY(U,$J,358.3,46514,0)
;;=E10.3292^^176^2314^27
;;^UTILITY(U,$J,358.3,46514,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46514,1,3,0)
;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Left Eye
;;^UTILITY(U,$J,358.3,46514,1,4,0)
;;=4^E10.3292
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2X1 3745 printed Nov 22, 2024@17:47:38 Page 2
IBDEI2X1 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46503,0)
+2 ;;=H34.8110^^176^2313^22
+3 ;;^UTILITY(U,$J,358.3,46503,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,46503,1,3,0)
+6 ;;=3^CRVO w/ CME,RIGHT eye
+7 ;;^UTILITY(U,$J,358.3,46503,1,4,0)
+8 ;;=4^H34.8110
+9 ;;^UTILITY(U,$J,358.3,46503,2)
+10 ;;=^5138476
+11 ;;^UTILITY(U,$J,358.3,46504,0)
+12 ;;=H34.8120^^176^2313^23
+13 ;;^UTILITY(U,$J,358.3,46504,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,46504,1,3,0)
+16 ;;=3^CRVO w/ CME,LEFT eye
+17 ;;^UTILITY(U,$J,358.3,46504,1,4,0)
+18 ;;=4^H34.8120
+19 ;;^UTILITY(U,$J,358.3,46504,2)
+20 ;;=^5138479
+21 ;;^UTILITY(U,$J,358.3,46505,0)
+22 ;;=H21.1X1^^176^2313^24
+23 ;;^UTILITY(U,$J,358.3,46505,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,46505,1,3,0)
+26 ;;=3^NVI/NVA/Rubeosis,RIGHT eye
+27 ;;^UTILITY(U,$J,358.3,46505,1,4,0)
+28 ;;=4^H21.1X1
+29 ;;^UTILITY(U,$J,358.3,46505,2)
+30 ;;=^5005175
+31 ;;^UTILITY(U,$J,358.3,46506,0)
+32 ;;=H21.1X2^^176^2313^25
+33 ;;^UTILITY(U,$J,358.3,46506,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,46506,1,3,0)
+36 ;;=3^NVI/NVA/Rubeosis,Left eye
+37 ;;^UTILITY(U,$J,358.3,46506,1,4,0)
+38 ;;=4^H21.1X2
+39 ;;^UTILITY(U,$J,358.3,46506,2)
+40 ;;=^5005176
+41 ;;^UTILITY(U,$J,358.3,46507,0)
+42 ;;=H35.711^^176^2313^26
+43 ;;^UTILITY(U,$J,358.3,46507,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,46507,1,3,0)
+46 ;;=3^Central Serous Retinopathy,RIGHT eye
+47 ;;^UTILITY(U,$J,358.3,46507,1,4,0)
+48 ;;=4^H35.711
+49 ;;^UTILITY(U,$J,358.3,46507,2)
+50 ;;=^5005703
+51 ;;^UTILITY(U,$J,358.3,46508,0)
+52 ;;=H35.712^^176^2313^27
+53 ;;^UTILITY(U,$J,358.3,46508,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,46508,1,3,0)
+56 ;;=3^Central Serous Retinopathy,LEFT eye
+57 ;;^UTILITY(U,$J,358.3,46508,1,4,0)
+58 ;;=4^H35.712
+59 ;;^UTILITY(U,$J,358.3,46508,2)
+60 ;;=^5005704
+61 ;;^UTILITY(U,$J,358.3,46509,0)
+62 ;;=E11.9^^176^2314^2
+63 ;;^UTILITY(U,$J,358.3,46509,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,46509,1,3,0)
+66 ;;=3^DM Type 2 w/o Complications
+67 ;;^UTILITY(U,$J,358.3,46509,1,4,0)
+68 ;;=4^E11.9
+69 ;;^UTILITY(U,$J,358.3,46509,2)
+70 ;;=^5002666
+71 ;;^UTILITY(U,$J,358.3,46510,0)
+72 ;;=E11.39^^176^2314^1
+73 ;;^UTILITY(U,$J,358.3,46510,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,46510,1,3,0)
+76 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
+77 ;;^UTILITY(U,$J,358.3,46510,1,4,0)
+78 ;;=4^E11.39
+79 ;;^UTILITY(U,$J,358.3,46510,2)
+80 ;;=^5002643
+81 ;;^UTILITY(U,$J,358.3,46511,0)
+82 ;;=E10.9^^176^2314^21
+83 ;;^UTILITY(U,$J,358.3,46511,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,46511,1,3,0)
+86 ;;=3^DM Type 1 w/o Complications
+87 ;;^UTILITY(U,$J,358.3,46511,1,4,0)
+88 ;;=4^E10.9
+89 ;;^UTILITY(U,$J,358.3,46511,2)
+90 ;;=^5002626
+91 ;;^UTILITY(U,$J,358.3,46512,0)
+92 ;;=E10.39^^176^2314^20
+93 ;;^UTILITY(U,$J,358.3,46512,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,46512,1,3,0)
+96 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
+97 ;;^UTILITY(U,$J,358.3,46512,1,4,0)
+98 ;;=4^E10.39
+99 ;;^UTILITY(U,$J,358.3,46512,2)
+100 ;;=^5002603
+101 ;;^UTILITY(U,$J,358.3,46513,0)
+102 ;;=E10.3291^^176^2314^22
+103 ;;^UTILITY(U,$J,358.3,46513,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,46513,1,3,0)
+106 ;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Right Eye
+107 ;;^UTILITY(U,$J,358.3,46513,1,4,0)
+108 ;;=4^E10.3291
+109 ;;^UTILITY(U,$J,358.3,46513,2)
+110 ;;=^5138283
+111 ;;^UTILITY(U,$J,358.3,46514,0)
+112 ;;=E10.3292^^176^2314^27
+113 ;;^UTILITY(U,$J,358.3,46514,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,46514,1,3,0)
+116 ;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Left Eye
+117 ;;^UTILITY(U,$J,358.3,46514,1,4,0)
+118 ;;=4^E10.3292
